Skip to main content
Max Financial Services Limited logo

Max Financial Services Limited — Investor Relations & Filings

Ticker · MFSL ISIN · INE180A01020 LEI · 335800Y9FX8XGFB64S40 BSE.NS Financial and insurance activities
Filings indexed 2,317 across all filing types
Latest filing 2025-06-04 Regulatory Filings
Country IN India
Listing BSE.NS MFSL

About Max Financial Services Limited

https://maxfinancialservices.com/

Max Financial Services Limited (MFSL) serves as the holding company for Max Life Insurance Company Limited, representing the Max Group's interests in the life insurance sector. The company focuses on providing a comprehensive suite of life insurance products, including protection, savings, investment, and retirement solutions. Through its subsidiary, it operates a multi-channel distribution network comprising agency forces, bancassurance partnerships—notably with Axis Bank—and digital platforms. MFSL emphasizes long-term value creation through customer-centric product innovation, robust risk management, and technological integration. The organization aims to enhance financial security for its diverse client base by offering tailored insurance plans and maintaining high claims settlement ratios. Its strategic focus remains on expanding market presence and driving operational efficiencies within the life insurance domain.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The document explicitly states that no unpublished price-sensitive information will be discussed and mentions that the investor presentation is already available on the company's website and stock exchanges. The content is an announcement about upcoming investor meetings and the availability of an investor presentation, not the presentation itself or a detailed financial report. The document length is short (2261 characters), and it serves as a notification rather than a full report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and disclosures that do not fit other specific categories.
2025-06-04 English
As per the disclosure attached
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing a schedule of analyst and institutional investor meetings. It explicitly states that no unpublished price-sensitive information will be discussed and refers to an investor presentation already available on the company's website. The document is a notification about upcoming investor meetings rather than the investor presentation itself or a financial report. It is relatively short (2384 characters) and serves as an announcement or update rather than a detailed report. Therefore, it fits best under Investor Presentation (IP) as it relates to investor communication and presentation scheduling, but since the actual presentation is not included and only the schedule is provided, it is more appropriate to classify it as Regulatory Filings (RNS) because it is a regulatory disclosure about investor meetings and presentation availability, not the presentation document itself.
2025-06-04 English
As per the disclosure attached
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing a schedule of analyst and institutional investor meetings. It explicitly states that no unpublished price-sensitive information will be discussed and refers to an investor presentation already available on the company's website. The document is a notification about upcoming investor meetings rather than the presentation itself or a detailed financial report. It is a regulatory announcement informing the stock exchanges and public about these meetings, fitting the category of Regulatory Filings (RNS). The document length is short (2261 characters), and it does not contain financial data or detailed report content, so it is not an Investor Presentation (IP) or Earnings Release (ER).
2025-06-04 English
Updates
Regulatory Filings
2025-05-28 English
As per the disclosure attached
Regulatory Filings
2025-05-28 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure letter addressed to stock exchanges regarding the grant of stock options under an ESOP plan. It details the number of options granted, the exercise price, and the vesting period. It explicitly states that no fresh issue of shares will be made and that shares will be acquired from the ESOP Trust. The document is short (2130 characters) and is an announcement of a corporate action related to employee stock options. It does not contain financial statements, audit information, or detailed financial results. It is not a report but a regulatory disclosure about capital structure related to stock options. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA), as it relates to changes in capital through stock options granted to employees.
2025-05-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.